Impact of Hyaluronic Acid and Bone Graft on Peri-Implant Tissue
Impact of Hyaluronic Acid and Bone Graft on PeriImplant Tissue Phenotype."A Randomized Controlled Trial"
This randomized controlled clinical trial aims to evaluate the effect of hyaluronic acid (HA) and particulate bone graft on the peri-implant tissue phenotype in patients receiving dental implants. Healthy adult participants requiring dental implant placement will be randomly allocated into one of three equal groups (12 implants per group): Group 1 will receive dental implants combined with hyaluronic acid gel (Gengigel); Group 2 will receive dental implants combined with both hyaluronic acid and particulate bone graft; and the control group will receive dental implants alone.
Clinical and radiographic assessments will be performed using a customized measurement stent to ensure standardized evaluations at baseline, immediately postoperatively, and at 8 and 16 weeks of follow-up. The primary and secondary outcomes include alterations in ridge width, keratinized tissue width/thickness, radiographic soft tissue height, and marginal bone height. The study aims to determine whether the adjunctive use of hyaluronic acid and bone grafts enhances the quality of the peri-implant soft and hard tissue phenotype.
研究概览
地位
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Babylon
-
Hillah、Babylon、伊拉克
- College of Dentistry, University of Babylon
-
Hillah、Babylon、伊拉克
- Private specialized dental center
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Adults ≥ 18 years old.
- Partially edentulous patients requiring dental implant placement.
- Good oral hygiene (Calibrated Gingival Bleeding Index (GBI) < 10%, O'Leary ---Plaque Index (PI) < 10%).
- Sufficient bone volume for implant placement.
Exclusion Criteria:
- Systemic conditions affecting bone healing (e.g., uncontrolled diabetes).
- Smoking > 10 cigarettes/day.
- Medications affecting bone metabolism (e.g., bisphosphonates).
- Active periodontal disease.
- Pregnant or lactating women.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Group 1: Dental Implants + Hyaluronic Acid
Patients receive dental implants combined with hyaluronic acid gel applied at the implant site.
|
Surgical placement of dental implants, followed by the application of hyaluronic acid gel at the implant site, was performed to evaluate its impact on peri-implant tissue phenotype.
|
|
实验性的:Group 2: Dental Implants + Hyaluronic Acid + Bone Graft
Patients receive dental implants combined with hyaluronic acid gel and particulate bone graft applied at the implant site.
|
Surgical placement of dental implants, combined with the application of hyaluronic acid gel and particulate bone graft at the implant site, was performed to evaluate its impact on peri-implant tissue phenotype.
|
|
有源比较器:Group 3: Control Group: Dental Implants Alone
Patients receive standard dental implants placement alone without any adjunctive materials.
|
Standard surgical placement of dental implants following conventional clinical protocols without the application of any adjunctive materials.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Ridge Width Changes (RW)
大体时间:Baseline (preoperative), immediate postoperative, 8 weeks, and 16 weeks.
|
The changes in Ridge Width is measured at the reference points using a digital vernier caliper.
|
Baseline (preoperative), immediate postoperative, 8 weeks, and 16 weeks.
|
|
Bone Width (BW)
大体时间:Baseline (preoperative), and 16 weeks postoperatively
|
Measured in millimeters by subtracting the buccal and lingual mucosal thickness from the ridge width.
|
Baseline (preoperative), and 16 weeks postoperatively
|
|
Change in width of keratinized tissue (KTW)
大体时间:Baseline (preoperative), 8 weeks, and 16 weeks
|
Measured in millimeters at the mid-buccal aspect of the implant site using an endodontic rotary file and digital vernier caliper.
|
Baseline (preoperative), 8 weeks, and 16 weeks
|
|
Keratinized Tissue Thickness (KTT)
大体时间:Baseline (preoperative), and 16 weeks postoperatively
|
Measured in millimeters at the buccal, crestal and lingual reference points using a periodontal probe and a digital vernier caliper.
|
Baseline (preoperative), and 16 weeks postoperatively
|
|
Radiographic Mucosal Thickness (RT)
大体时间:Baseline (preoperative), immediate postoperative, 8 weeks, and 16 weeks
|
Measured in millimeters on periapical radiographs using digital software from the crestal bone level to the crest of crestal oral mucosa 5 mm away from the height distal surface of the adjacent tooth on the mesial side of the implant.
|
Baseline (preoperative), immediate postoperative, 8 weeks, and 16 weeks
|
|
Crestal Bone Height (BH)
大体时间:Immediate postoperative, 8 weeks, and 16 weeks
|
Measured in millimeters on periapical radiographs using digital software from the second serration on the mesial side of the implant to the crest of the bone.
|
Immediate postoperative, 8 weeks, and 16 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Plaque Index (PI)
大体时间:Baseline (preoperative), 8 weeks, and 16 weeks
|
O'Leary plaque index
|
Baseline (preoperative), 8 weeks, and 16 weeks
|
|
Gingival Index (GI)
大体时间:Baseline (preoperative), 8 weeks, and 16 weeks
|
Gingival Bleeding Index
|
Baseline (preoperative), 8 weeks, and 16 weeks
|
|
Postoperative Pain Scores
大体时间:Three times daily (morning, afternoon, and evening) for the first 7 days postoperatively
|
Patients received a standardized pain assessment chart for self-evaluation over seven consecutive postoperative days.
This chart featured an 11-point (0-10) Numerical Rating Scale (NRS) integrated with the Wong-Baker Faces Pain Rating Scale and supplemented with descriptive pain expressions ranging from a minimum value of 0 (representing no pain) to a maximum value of 10 (representing the worst possible pain), where higher scores indicate a worse outcome (greater pain severity).
|
Three times daily (morning, afternoon, and evening) for the first 7 days postoperatively
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- MUOSU/POST-202615
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.